“Our expertise is a Swiss speciality”

SIB Director Christine Durinx was interviewed by L’AGEFI, a Swiss daily newspaper focused on economics, finance and politics.

Bringing Swiss health data to biomedical research: an interoperability journey

Health data from patients are typically generated and stored in a multitude of ways across Swiss hospitals. Making these data both accessible and useful to biomedical researchers is the goal of the Swiss Personalized Health Network initiative (SPHN).

August publications

Take a tour of SIB members' latest peer-reviewed articles and conference proceedings

Molecular Big Data, a new weapon for medicine - Experts will meet in Switzerland in September

Being able to visualize the transmission of a virus in real-time during an outbreak, or to better adapt cancer treatment on the basis of the mutations present in a tumour’s individual cells are only two examples of what molecular Big Data can bring to medicine and health globally...

Latest Protein Spotlight: The scent of guile

Because of their inability to move, plants have devised the most elaborate ways of deceiving their environment in order to grow. European maize, for example, is able to synthesize a molecule known as (E)-β-caryophyllene which is released by the plant's leaves and roots in the presence of larvae feeding on them.

July publications

Take a tour of SIB members' latest peer-reviewed articles and conference proceedings

A new approach to unravel genetic determinants of complex and clinical traits

Eleonora Porcu from the SIB Group of Zoltán Kutalik at the University of Lausanne proposes a Transcriptome-Wide Mendelian Randomization method (TWMR) which, applied to 43 complex traits, uncovers hundreds of previously unreported gene-trait associations.

Next generation molecular medicine: unlocking big data for precision oncology and infectious disease

Join the international [BC]2 conference and EMBO meeting at BASEL LIFE from 9–12 September: a unique opportunity for today’s scientists to get insights and share the latest discoveries, resources and approaches to make sense of genomic and health-related “big data” for molecular medicine – from precision oncology to infectious diseases.

Previous news